A new treatment option has become available in the local esophageal cancer treatment market, where only chemotherapies existed for more than 60 years.
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer treatment market, where only chemotherapies existed for more than 60 years.